Compare Tango Therapeutics Inc. (TNGX) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tango Therapeutics Inc. vs Utilities Select Sector SPDR Fund — how do they compare? Tango Therapeutics Inc. trades at $22.5 (market cap $3.75B), while Utilities Select Sector SPDR Fund trades at $41.95 (market cap $24.20B). The key difference: Utilities Select Sector SPDR Fund is far larger — about 6.5× Tango Therapeutics Inc.'s market cap, and Tango Therapeutics Inc. is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tango Therapeutics Inc. for 0 Days and Utilities Select Sector SPDR Fund for 81 Days on average.
| TNGX | XLU | |
|---|---|---|
Market Cap | $3.75B | $24.20B |
Volume | 9,619,106 | 27,226,247 |
Sector | Health | — |
52-Week High | $32.90 | $47.73 |
52-Week Low | $7.50 | $39.25 |
Typical Hold Time | 0 Days | 81 Days |
Enterprise Value | $2.77B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
XLU trades at $41.87, up 0.58% on the day, but remains under pressure after hitting recent 52-week lows near $39.13. Technical indicators show mixed signals with a bullish moving average trend but bearish oscillators, including an overbought RSI. The utilities sector faces headwinds from rising interest rates and regulatory challenges, particularly affecting data-center demand growth.
The outlook remains cautious as utility stocks face macro pressures from interest rates and regulatory uncertainty. While defensive characteristics provide some stability, near-term performance depends on interest rate direction and AI power demand evolution. Risk-reward appears balanced with potential for recovery if macro conditions stabilize.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
